Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, April 14, 2026.
State Street SPDR S&P Biotech ETF (PACF:XBI)
Strong Uptrend (+100) - XBI is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, XBI continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid XBI?
MarketClub looks at technical strength and momentum to determine if the timing is right for XBI.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XBI
The long-term trend has been UP since Jul 9th, 2025 at 85.96
The intermediate-term trend has been UP since Apr 1st, 2026 at 129.11
The short-term trend has been UP since Mar 31st, 2026 at 125.64
Smart Scan Analysis for XBI
Based on our trend formula, XBI is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 133.20 | 136.40 | 133.03 | 135.72 | +3.67 |
| Prev. Close | Volume | Bid | Ask | Time |
| 132.05 | 10659699 | 2026-04-14 15:59:44 |
| Year High | 101.55 | Year High Date | 2018-06-21 |
| Year Low | 73.97 | Year Low Date | 2018-11-14 |
| 52wk High | 133.6 | 52wk High Date | 2026-04-13 |
| 52wk Low | 73.935 | 52wk Low Date | 2025-04-16 |
| Year End Close | 87.91 | Average Volume | 10,175,080 |
| Shares Outstanding | 25,500 | Assets | 7,417M |
| Beta | 1 | Volatility | 45.58 |